2014
Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling
Dowdy DW, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies NA, Gomez GB, Langley I, Squire SB, White R, for the TB MAC meeting participants. Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. The International Journal Of Tuberculosis And Lung Disease 2014, 18: 1012-1018. PMID: 25189546, PMCID: PMC4436823, DOI: 10.5588/ijtld.13.0851.Peer-Reviewed Original ResearchConceptsTB diagnosticsDrug susceptibility testingNew drug regimensUrgent guidanceDrug regimensDiagnostic testingTuberculosis diagnosticsSusceptibility testing
2012
The impact of new tuberculosis diagnostics on transmission: why context matters
Lin HH, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin Of The World Health Organization 2012, 90: 739-747. PMID: 23109741, PMCID: PMC3471051, DOI: 10.2471/blt.11.101436.Peer-Reviewed Original ResearchConceptsNew tuberculosis diagnosticsNew diagnostic toolsPatient lossHuman immunodeficiency virus (HIV) infectionTuberculosis diagnosticsSmear-negative pulmonary tuberculosisDiagnostic toolImmunodeficiency virus infectionTreatment success rateSmear-negative casesIncidence of tuberculosisEpidemiology of tuberculosisPatient defaultPulmonary tuberculosisTuberculosis careDiagnostic pathwayTuberculosis transmissionSymptomatic individualsVirus infectionSmear microscopyTuberculosisAnnual declineDiagnosisAbsolute changeSuccess rate